Ritzman adds specialty Rx capabilities to arsenal
With the launch of specialty pharmacy services, Ritzman Pharmacies had one of its most successful years in 2014.
CDR
Lewis Drug steps up its pace of expansion
Last year brought dramatic expansion for Lewis Drug, as it acquired 12 stores in three states. The pickups brought the chain’s store count at the start of 2015 to 46, and more purchases are in the works. In the first half of 2014 the retailer bought a half-dozen independent outlets across
Perrigo rejects formal bid from Mylan
For the second time this week, Perrigo Co. plc has rejected an acquisition offer from Mylan N.V. On Friday morning, Mylan announced a formal offer to buy Perrigo for $60 per share in cash and 2.2 Mylan ordinary shares for each Perrigo ordinary share. Based on the prior day’s close, the deal
Carma Labs appoints VP of R&D
Keith Edgett has joined Carma Laboratories Inc., the maker of Carmex lip balm products, as vice president of research and development. Carma said Friday that in the role, Edgett is responsible for leading all areas of product development, global regulatory compliance and product innovation.
Nipro set to launch True Metrix Air
Nipro Diagnostics Inc. has gained approval from the Food and Drug Administration for the True Metrix Air Self-Monitoring blood glucose system, which enables people with diabetes to test blood glucose and deliver data wirelessly to a smartphone.
RB recalls Mucinex products
Reckitt Benckiser (RB) has recalled certain lots of liquid bottles of its over-the-counter Mucinex Fast-Max cough/cold medicines because of a labeling discrepancy. RB said the voluntary recall, announced this week, stemmed from a confirmed report by a retailer.
Jean Coutu Group connects with its customers
Through its ability to forge solid relationships with shoppers, both those in the pharmacy and those at the front end, the Jean Coutu Group has been able to retain loyal customers as well as attract new clientele, according to president and chief executive officer François Coutu.
Prestige Brands CEO Mannelly to retire
Matthew Mannelly is retiring as president and chief executive officer of Prestige Brands Holdings Inc. and will be succeeded by chief financial officer Ron Lombardi. Prestige Brands said late Wednesday that Mannelly is slated to retire on June 1.
NCPA provides video training for med sync
The National Community Pharmacists Association (NCPA) has launched “Implementing Med Sync,” a six-part video training series for community pharmacies that want to set up an appointment-based medication synchronization program in their stores.
Febreze Tabletop Air Purifier carried by CVS
Kaz USA Inc.’s new Febreze Tabletop Air Purifier, designed to help combat allergens, is being sold in the allergy aisle at select CVS/pharmacy stores nationwide.
Publix reaches pharmacy milestone
Publix Super Markets Inc. this month marked a milestone for its pharmacies by surpassing 50 million free prescriptions for customers in the past eight years.
Novo Nordisk releases Saxenda weight-control pen in U.S.
Novo Nordisk Inc. has launched Saxenda, a weight-control drug delivered via an injector pen, in the United States. The company said Wednesday that Saxenda (liraglutide injection) is the first, once-daily glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management in adults.
National Sales Solutions names international sales VP
National Sales Solutions (NSS) has hired Doug Mackenzie as vice president of international sales. The consumer packaged goods sales and marketing firm said Tuesday that Mackenzie will work with clients looking to expand distribution and grow their business outside of the United States.
Partnership brings specialty Rx services to independents
The Academy of Independent Pharmacy (AIP) and Aureus Health Services have partnered to provide specialty pharmacy services to independent retail pharmacies.
Report: Restrictive drug plan regs cost consumers
Community pharmacies are likely to take exception to some of the findings in a new report from the National Center for Policy Analysis (NCPA), titled “New Drug Plan Regulations Protect Pharmacies, Harm Consumers”.